-
Diagnostics World | After decades of false starts, digital pathology adoption is finally happening. Pathologists in these labs don’t have glass slides anywhere in their offices and have completely adapted their workflow and mindset to a digital world. They experience ‘faster than glass’ workflow advantages and tangible benefits associated with AI tools, but also have learned important lessons along the path to adoption.
May 31, 2024
-
Diagnostics World | Quest Diagnostics and PathAI announced a multi-faceted collaboration designed to accelerate the adoption of digital and AI pathology innovations; Ambry Genetics and PacBio were selected to support the Pediatric Mendelian Genomics Research Center (MGRC) program; Foundation Medicine launches FoundationOne RNA; more.
May 29, 2024
-
Diagnostics World | Karius plans extend its reach beyond the 400 U.S. hospitals currently using the Karius Test, an infectious disease diagnostic test that utilizes genomic analysis and artificial intelligence to detect over 1,000 pathogens from a single blood sample; PinkDx launches to pursue its vision of identifying unmet medical needs that are unique to women; En Carta develops a point-of-care diagnostic for Lyme disease; more.
May 28, 2024
-
Diagnostics World | Using an artificial intelligence (AI) model that was trained on millions of variants from identified genetic disorders and incorporates the complex decision-making process of human molecular scientists, investigators at Baylor College of Medicine are on track to automate the diagnosis of an enormous number of undiagnosed conditions.
May 23, 2024
-
Diagnostics World | Researchers at the University of Michigan (U-M) have developed a urine test for prostate cancer known as MyProstateScore 2.0 (MPS2), now a property of spinoff LynxDx, which they expect to significantly improve upon the performance of existing assays by focusing on clinically significant cancers and capturing more biomarkers in a single test.
May 21, 2024